Zengos extensive prior experience treating hypothyroid in pregnancy has made him a regional consultant for management of hypothyroid in pregnancy
In addition, long-term use of GLP-1RAs may also have potential safety risks, such as pancreatitis (Shetty et al., 2022) and thyroid diseases ( 6 Discussion T2DM is a chronic disease characterized by hyperglycemia, which eventually leads to microvascular damage and macrovascular events, as well as complications related to peripheral vascular diseases
Injections can correct this by helping your body produce more tryptophan
What the research has found so far A 2025 cross-sectional analysis of the FDA Adverse Event Reporting System (FAERS) database, conducted by researchers at Stanford University, identified 182 reported cases of sexual adverse events associated with GLP-1 receptor agonists
Only a qualified physician in your state can determine if you qualify for and should undertake treatment.
[1] Tirzepatide is not recommended for patients with severe gastrointestinal disease, including severe gastroparesis